Reporter Gene Assay Global Market Report 2024

A reporter gene assay is a molecular biology technique employed to investigate gene expression and regulatory sequences. It utilizes a reporter gene, which encodes a measurable product.

The primary types of products in the reporter gene assay market include assay kits and reagents. Assay kits play a pivotal role in scientific research and clinical diagnostics by offering a consistent, reliable, and often high-throughput method for conducting intricate tests. These kits find diverse applications such as promoter structural and functional analysis, examination of cell signaling pathways, protein interaction studies, clinical diagnostics, and gene regulation. They are utilized by various end-users including biotechnology and pharmaceutical firms, research and academic institutions, hospital and diagnostic laboratories, and contract research organizations.

The reporter gene assay market research report is one of a series of new reports that provides reporter gene assay market statistics, including reporter gene assay industry global market size, regional shares, competitors with a reporter gene assay market share, detailed reporter gene assay market segments, market trends and opportunities, and any further data you may need to thrive in the reporter gene assay industry. This reporter gene assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The reporter gene assay market size has grown strongly in recent years. It will grow from $5.88 billion in 2023 to $6.39 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. Historic period growth can be credited to increasing demand for cell-based assays, advancements in genomics research, heightened focus on drug discovery and development, escalating need for personalized treatment, and a growing emphasis on early diagnosis.

The reporter gene assay market size is expected to see strong growth in the next few years. It will grow to $9.03 billion in 2028 at a compound annual growth rate (CAGR) of 9%. Forecasted growth is expected due to the rising prevalence of chronic genetic disorders, increasing demand for personalized medicine, expanding utilization of molecular imaging systems, broadening of gene therapy portfolios, and governmental initiatives. Major trends in the forecast period encompass technological advancements in gene therapy, progress in molecular biology, the demand for advanced molecular diagnostic tools, a shift towards 3D cell culture models, and strategic partnerships.

The growth of the reporter gene assay market is expected to be driven by the increasing focus on drug discovery and development research. This research entails a systematic approach in medical, biotechnology, and pharmacology fields to discover, create, and introduce new medications. Advances in proteomics, high-throughput screening, genomics, and successful development of novel medications contribute to this trend. Reporter gene assays are essential tools in this research, enabling insights into gene regulation, identification of drug targets, screening of compound libraries, and evaluation of drug efficacy and safety. For example, in April 2024, the UK government's expenditure on research and development rose by 10.5% from the previous year, underscoring the driving force of increased drug discovery and development on the reporter gene assay market.

Leading companies in the reporter gene assay market are concentrating on innovative solutions such as ultrasensitive multiplexed digital PCR assays to enhance their market position. These assays, such as Bio-Rad Laboratories Inc.'s ddPLEX ESR1 Mutation Detection Kit launched in April 2024, detect and quantify nucleic acids with high precision by dividing samples into numerous reactions containing minute amounts of target DNA or RNA molecules. This ultrasensitive assay offers exceptional sensitivity for detecting minor mutations in complex samples, particularly beneficial for early disease monitoring in breast cancer. Its multiplexing capability allows simultaneous detection of multiple mutations, streamlining testing and potentially transforming breast cancer research and personalized treatment strategies.

In January 2023, Qiagen N.V., a German biotechnology company, acquired Verogen Inc. to strengthen its footprint in forensic genomics and DNA analysis. This acquisition integrates Verogen's specialized sequencing technologies and analysis software tailored for forensic applications into Qiagen's portfolio, expanding its capabilities in this specialized field. Verogen Inc. is a US-based company providing reporter gene assays.

Major companies operating in the reporter gene assay market are Roche Diagnostics, Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD Biosciences), GE Healthcare, Lonza Group, Agilent Technologies, Sartorius AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., GenScript Biotech Corporation, Abcam plc, Promega Corporation, Promega Corporation, Takara Bio Inc., New England Biolabs (NEB), OriGene Technologies Inc., Cell Signaling Technology Inc., SABiosciences, Enzo Biochem Inc., InvivoGen, Biotium Inc., Enzo Life Sciences Inc., BioAssay Systems, Indigo Biosciences Inc.

North America was the largest region in the reporter gene assay market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the reporter gene assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the reporter gene assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reporter gene assay market consists of revenues earned by entities by providing services such as cell culture services, assay development, assay validation, high-throughput screening, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The reporter gene assay market also includes consists sales of transfection reagents, reporter gene detection kits, assay validation controls, assay optimization kits, and high-throughput screening platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.